Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/
Study sponsor: Pliant Therapeutics, Inc. · PLRX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-06-27Actual
Enrollment · participants9Actual
Source updated2023-12-12Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.